Benzinga | Aug 12, 2020 08:34AM EDT

Eton Pharmaceuticals Q2 EPS $(0.23) Beats $(0.26) Estimate, Sales $20.00K Miss $290.00K Estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.26) by 11.54 percent. This is a 27.78 percent decrease over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $20.00 thousand which missed the analyst consensus estimate of $290.00 thousand by 93.10 percent.